DK1251842T3 - Anvendelse af modafinil til fremstilling af et lægemiddel til korrigering af forstyrrelser af den vågne tilstand, der er forbundet med myopatier - Google Patents

Anvendelse af modafinil til fremstilling af et lægemiddel til korrigering af forstyrrelser af den vågne tilstand, der er forbundet med myopatier

Info

Publication number
DK1251842T3
DK1251842T3 DK01903990T DK01903990T DK1251842T3 DK 1251842 T3 DK1251842 T3 DK 1251842T3 DK 01903990 T DK01903990 T DK 01903990T DK 01903990 T DK01903990 T DK 01903990T DK 1251842 T3 DK1251842 T3 DK 1251842T3
Authority
DK
Denmark
Prior art keywords
modafinil
myopathies
medicament
disorders
correction
Prior art date
Application number
DK01903990T
Other languages
English (en)
Inventor
Fabrice Battaglia
Christophe Petiau
Helene Bastuji
Jean Krieger
Christophe Vial
Serge Lubin
Original Assignee
Cephalon France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon France filed Critical Cephalon France
Application granted granted Critical
Publication of DK1251842T3 publication Critical patent/DK1251842T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
DK01903990T 2000-01-31 2001-01-29 Anvendelse af modafinil til fremstilling af et lægemiddel til korrigering af forstyrrelser af den vågne tilstand, der er forbundet med myopatier DK1251842T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001211A FR2804322B1 (fr) 2000-01-31 2000-01-31 Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
PCT/FR2001/000271 WO2001054648A2 (fr) 2000-01-31 2001-01-29 Traitement des troubles de la vigilance associes aux myopathies

Publications (1)

Publication Number Publication Date
DK1251842T3 true DK1251842T3 (da) 2003-12-22

Family

ID=8846505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01903990T DK1251842T3 (da) 2000-01-31 2001-01-29 Anvendelse af modafinil til fremstilling af et lægemiddel til korrigering af forstyrrelser af den vågne tilstand, der er forbundet med myopatier

Country Status (13)

Country Link
US (1) US6462089B1 (da)
EP (1) EP1251842B1 (da)
JP (2) JP2003521487A (da)
AT (1) ATE247956T1 (da)
AU (1) AU2001231931A1 (da)
DE (1) DE60100660T2 (da)
DK (1) DK1251842T3 (da)
ES (1) ES2206400T3 (da)
FR (1) FR2804322B1 (da)
MX (1) MXPA02007236A (da)
PT (1) PT1251842E (da)
TR (1) TR200300575T3 (da)
WO (1) WO2001054648A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283008A1 (en) * 2000-07-27 2002-02-13 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
CA2556106A1 (en) * 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
CN100343228C (zh) * 2006-02-17 2007-10-17 中国科学院上海有机化学研究所 高对映体选择性制备 2－二苯甲基亚磺酰基－乙酰胺单一对映体的方法
WO2008003093A2 (en) * 2006-06-29 2008-01-03 Questcor Pharmaceuticals, Inc. Pharmaceutical compositions and related methods of treatment
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue

Also Published As

Publication number Publication date
MXPA02007236A (es) 2003-09-05
DE60100660D1 (de) 2003-10-02
DE60100660T2 (de) 2004-02-26
WO2001054648A2 (fr) 2001-08-02
ATE247956T1 (de) 2003-09-15
US6462089B1 (en) 2002-10-08
AU2001231931A1 (en) 2001-08-07
TR200300575T3 (tr) 2003-06-23
ES2206400T3 (es) 2004-05-16
EP1251842A2 (fr) 2002-10-30
EP1251842B1 (fr) 2003-08-27
FR2804322A1 (fr) 2001-08-03
WO2001054648A3 (fr) 2002-06-06
PT1251842E (pt) 2004-01-30
FR2804322B1 (fr) 2002-04-19
JP2012197304A (ja) 2012-10-18
JP2003521487A (ja) 2003-07-15

Similar Documents

Publication Publication Date Title
DK1066036T3 (da) Midler med serotoninrelateret aktivitet til behandling af sövnapnö
NO20052591D0 (no) Pyridopyrolizin og pyridoindolizinderivater
PL350453A1 (en) N−cyanomethyl amides as protease inhibitors
DK1263504T3 (da) Anvendelse af forbindelser med 5-HT1A aktivitet, som er anvendelige til behandling af lidelser i den ydre retina
DK1251842T3 (da) Anvendelse af modafinil til fremstilling af et lægemiddel til korrigering af forstyrrelser af den vågne tilstand, der er forbundet med myopatier
MY135841A (en) Novel benzodioxoles
DK1615647T3 (da) Farmaceutisk anvendelse af kondenserede 1,2,4-triazoler
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
WO2006138508A3 (en) Benzamide derivatives and uses related thereto
MXPA05013733A (es) 2-aminobenzotiazoles como agonistas inversos del receptor de cb1.
DK1735296T3 (da) Materialer og fremgangsmåder til behandling af koagulationslidelser
DK1339406T3 (da) Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
PL1620425T3 (pl) Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
ATE406887T1 (de) R-bambuterol, seine herstellung und therapeutische verwendungen
DK1809270T3 (da) 5,6,7-trihydroxyheptansyre og analoger til behandling af okulære sygdomme og sygdomme associeret med hyperproliferative og angiogeniske reaktioner
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
SE0200198D0 (sv) New use
NO20033413L (no) Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
NO20050146L (no) N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon